🟢 Anixa Biosciences is trading 5% up in after-hours trading with no clear company-specific catalyst

Anixa Biosciences is trading 5.24% higher now at $2.81 after-hours, with no clear company-specific catalyst identified.

• It closed at $2.67 on October 13, after a 5.99% regular-session decline.
• The company announced that the inventor of its ovarian cancer CAR-T therapy will deliver a keynote at a November conference. The announcement reported no new trial results and did not establish a reason for the after-hours rebound.